Literature DB >> 22052882

Primary IgA nephropathy in north India: is it different?

Neha Mittal1, Kusum Joshi, Swapnil Rane, Ritambhra Nada, Vinay Sakhuja.   

Abstract

BACKGROUND: Immunoglobulin A (IgA) nephropathy is the most common glomerulonephritis worldwide, but has a variable geographic distribution. the bulk of the disease burden is borne by asian countries. however, its exact prevalence or clinicopathologic spectrum in india is not well documented.
METHODS: This cross sectional study analysed the renal biopsy findings and clinical features at presentation in 66 patients of primary IgA nephropathy diagnosed over a period of 2 years (2007-2008). The results were compared with studies from other centres in the country and elsewhere.
RESULTS: IgA nephropathy comprised 8.1% of all native kidney biopsies. The mean age of the patients was 29.9 years with a male:female ratio of 4.4:1. Most patients presented with renal failure and a significant percentage (23%) also had nephrotic range proteinuria. Renal biopsies were classified by the Haas classification and were further scored by the MEST scoring system of the Oxford classification. By Haas classification, 41 cases (62%) showed advanced sclerotic lesions of class V. Active crescents (cellular or fibrocellular) were seen in 42% of cases, and 26% of cases showed endocapillary proliferation. Serum creatinine values were highest in the presence of proliferative lesions. MEST scoring of the Oxford classification was not applicable in approximately 18% of cases because of the presence of advanced sclerotic lesions. On immunofluorescence, the majority of the cases showed both mesangial and membranous positivity for IgA antisera. Electron microscopy revealed para-mesangial location of immune complex deposition in the majority of the cases. It also showed glomerular basement membrane abnormalities in two cases.
CONCLUSION: Comparison of clinical and pathological features revealed that this disease presents as an advanced disease in much younger individuals in this study compared to other studies. Elucidation of the underlying factors may have immense therapeutic implications.

Entities:  

Mesh:

Year:  2011        PMID: 22052882     DOI: 10.1136/postgradmedj-2011-130077

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  13 in total

1.  Oxford classification of IgA nephropathy: Broadening the scope of the classification.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2012-04-05

2.  Oxford-MEST classification in IgA nephropathy patients: A report from Iran.

Authors:  Hamid Nasri; Mojgan Mortazavi; Ali Ghorbani; Heshmatollah Shahbazian; Soleiman Kheiri; Azar Baradaran; Afsoon Emami-Naieni; Maryam Saffari; Saeed Mardani; Ali Momeni; Yahya Madihi; Milad Baradaran-Ghahfarokhi; Mahmoud Rafieian-Kopaie; Parin Hedayati; Shahzad Baradaran; Mohammadreza Ardalan; Shahram Sajjadieh; Naziheh Assarzadegan; Seyed Mohammad Ahmadi Soleimani; Mohamad Reza Tamadon
Journal:  J Nephropathol       Date:  2012-04-05

Review 3.  Extracapillary proliferation in IgA nephropathy; recent findings and new ideas.

Authors:  Hamid Nasri; Muhammed Mubarak
Journal:  J Nephropathol       Date:  2015-01-01

4.  Histopathological and immune alterations in autopsied kidneys.

Authors:  Ufuk Usta; Ebru Tastekin; Erhan Isler; Ali K Kutlu; Fulya Oz Puyan
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

5.  IgA Nephropathy in Salvador, Brazil. Clinical and laboratory presentation at diagnosis.

Authors:  Brenda Navarro de Souza; Maria Brandão Tavares; Maria Fernanda Sanches Soares; Washington Luis Conrado Dos Santos
Journal:  J Bras Nefrol       Date:  2018-05-07

6.  Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.

Authors:  Soumita Bagchi; Raghavendra Lingaiah; Kalaivani Mani; Adarsh Barwad; Geetika Singh; Veena Balooni; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

7.  Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function.

Authors:  Min Tan; Jing Fang; Qianqian Xu; Cong Zhang; Guming Zou; Min Wang; Wenge Li
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

8.  Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy.

Authors:  R P Goswami; D Sinha; S Mondal; S Mandal; T Ete; A Nag; J Pal; A Roychowdhury; A Ghosh
Journal:  Indian J Nephrol       Date:  2013-09

9.  Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort.

Authors:  Suceena Alexander; George T John; Anila Korula; T S Vijayakumar; Vinoi George David; Anjali Mohapatra; Anna T Valson; Shibu Jacob; Pradeep Mathew Koshy; Gautam Rajan; Elenjickal Elias John; Smita Mary Matthai; L Jeyaseelan; Babu Ponnusamy; Terence Cook; Charles Pusey; Mohamed R Daha; John Feehally; Jonathan Barratt; Santosh Varughese
Journal:  Wellcome Open Res       Date:  2018-07-26

10.  Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study.

Authors:  Soumita Bagchi; Kalaivani Mani; Anitha Swamy; Adarsh Barwad; Geetika Singh; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  Kidney Int Rep       Date:  2021-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.